Abivax S.A. - Ordinary Shares, par value Euro 0.01 per share (ABVX)

Historical Holders from Q4 2023 to Q3 2025

Symbol
ABVX on Nasdaq
CUSIP
00370M103
Type / Class
Equity / Ordinary Shares, par value Euro 0.01 per share
Shares outstanding
78.1M
All holders as of September 30, 2025
Q3 2025
Total 13F shares, excl. options
52M
Holdings value
$4.41B
% of all portfolios
0.028%
Grand Portfolio weight change
+0.003%
Number of holders
164
Number of buys
144
Number of sells
-24
Average Value change %
+0%
Average buys %
+0.014%
Average sells %
-0.011%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of Abivax S.A. - Ordinary Shares, par value Euro 0.01 per share (ABVX)

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
Sofinnova Crossover I 9.4% -18.2% $713M -$102M 8.4M -12.5% Sofinnova Crossover I SLP Oct 28, 2025
TCG Crossover GP I, LLC 9.1% $604M 7.11M Chen Yu Sep 30, 2025
Invus Global Management, LLC 8.5% $37.4M 5.4M Invus Public Equities, L.P. Sep 2, 2022
Deep Track Capital, LP 4.78% $28.9M 3.48M Deep Track Capital, LP Jun 30, 2025
Venrock Healthcare Capital Partners III, L.P. 0.8% $49M 577K Venrock Healthcare Capital Partners III, L.P. Sep 30, 2025

Institutional Holders of Abivax S.A. - Ordinary Shares, par value Euro 0.01 per share (ABVX)

Period Reported Shares, Excl. Options Value, Excl. Options Change Price Investors
2025 Q3 52M $4.41B +$2.13B $84.90 164
2025 Q2 30.7M $235M -$5.69M $7.65 43
2025 Q1 31.8M $199M +$9.16M $6.25 46
2024 Q4 29.9M $219M +$7.33M $7.32 47
2024 Q3 27.4M $313M -$8.25M $11.52 40
2024 Q2 28.1M $372M +$62.5M $13.22 38
2024 Q1 23.4M $334M +$31.8M $14.30 36
2023 Q4 21.3M $228M +$228M $10.70 30